Because apoptosis inhibition is one of the causes of cisplatin resistance [15,16], exploring the relationship between RRS1 and cisplatin resistance in breast cancer cells may determine the potential of ribosomal proteins as therapeutic targets. The gene discussed is RRS1; the disease is breast cancer.